Use of Human Lung Tissue Models for Screening of Drugs against SARS-CoV-2 Infection

Use of Human Lung Tissue Models for Screening of Drugs against SARS-CoV-2 Infection

The repurposing of licenced drugs for use against COVID-19 is one of the most rapid ways to develop new and alternative therapeutic options to manage the ongoing pandemic. Given circa 7817 licenced compounds available from Compounds Australia that can be screened, this paper demonstrates the utility...

ver descrição completa

Detalhes bibliográficos
Principais autores: Alexander J. McAuley, Petrus Jansen van Vuren, Muzaffar-Ur-Rehman Mohammed, Faheem, Sarah Goldie, Shane Riddell, Nathan J. Gödde, Ian K. Styles, Matthew P. Bruce, Simran Chahal, Stephanie Keating, Kim R. Blasdell, Mary Tachedjian, Carmel M. O’Brien, Nagendrakumar Balasubramanian Singanallur, John Noel Viana, Aditya V. Vashi, Carl M. Kirkpatrick, Christopher A. MacRaild, Rohan M. Shah, Elizabeth Vincan, Eugene Athan, Darren J. Creek, Natalie L. Trevaskis, Sankaranarayanan Murugesan, Anupama Kumar, Seshadri S. Vasan
Formato: Artigo
Idioma:English
Publicado em: MDPI AG 2022-10-01
coleção:Viruses
Assuntos:
COVID-19
CoviRx.org
therapeutics
drug repurposing
3D tissue models
Acesso em linha:https://www.mdpi.com/1999-4915/14/11/2417

Internet

https://www.mdpi.com/1999-4915/14/11/2417

Registros relacionados